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  EVIDENCE-BASED ANSWER 
Either oral or vaginal metronidazole or vaginal clindamycin provides equivalent treatment for bacterial vaginosis 
in nonpregnant women (TABLE). Oral clindamycin 300 mg twice daily for 7 days is an effective alternative. 
There is conflicting evidence regarding the efficacy of a single 2-g dose of oral metronidazole. Ofloxacin 200 mg 
or 300 mg twice daily is less effective but could be considered for women with intolerance to metronidazole or 
clindamycin. Overall recurrence rates of up to 30% have been reported. (Grade of recommendation: A, based 
on systematic reviews and randomized controlled trials) 
  EVIDENCE SUMMARY 
One systematic review calculated cure rates from 5 randomized controlled trials comparing oral metronidazole, 
clindamycin 2% vaginal cream, and metronidazole 0.75% vaginal gel.2 Cumulative cure rates at 5 to 10 days 
and 4 weeks post-treatment were essentially equal for all treatments TABLE 1. The most common side effects 
were vaginal Candida infections (for both treatments) and gastrointestional symptoms (for metronidazole tablets 
and gels). 
Metronidazole 0.75% gel used once daily for 5 days had equal efficacy compared with twice-daily dosing (cure 
rate = 77% vs 80%).3 One study found a cure rate of 94% with oral clindamycin 300 mg twice daily for 7 days 
and 96% with metronidazole 500 mg twice daily for 7 days. 
A meta-analysis of 10 clinical trials compared different dosing regimens of oral metronidazole.4 The results 
showed comparable cure rates (85% to 87%) among groups treated with either a single 2-g dose or 500 mg 
twice daily for 7 days. A systematic review showed a significantly lower cure rate with a single 2-g dose 
compared with the 7-day regimen (54% vs 88%).5 
Metronidazole (400 mg or 500 mg twice daily) achieved significantly higher cure rates compared with ofloxacin 
(200 mg or 300 mg twice daily) 1 to 7 days post-treatment.6,7 One review reports that ampicillin and 
erythromycin are ineffective and ampicillin sulbactam and ciprofloxacin are less effective than oral 
metronidazole.8 A systematic review of 4 studies on treatments to restore depleted Lactobacilli concluded that 
“these trials do not constitute enough evidence to recommend using yogurt or Lactobacillus to cure vaginal 
infections.”9 One systematic review of 6 randomized controlled trials found no benefit from treating male 
partners of women with bacterial vaginosis.10 
  RECOMMENDATIONS FROM OTHERS 
The Clinical Effectiveness Group and the American College of Obstetricians and Gynecologists recommend: (1) 
2% clindamycin cream 5 g at bedtime for 7 days or 300 mg orally twice daily for 7 days; or (2) metronidazole 
gel, 0.75% 5 g twice daily for 5 days or 500 mg orally twice daily for 7 days.11,12 
CLINICAL COMMENTARY 
Robert  Pierce,  MD, MSPH 
Fulton Family Health Associates, Missouri 
The evidence presented is consistent with my practice of treating patients with bacterial 
vaginosis. I treat the vast majority of patients with metronidazole 500 mg orally twice daily 
for a week. Sometimes I prescribe clindamycin cream or metronidazole gel, but patients 
seem to prefer oral therapy, despite the higher likelihood of side effects. I usually reserve 
oral clindamycin for treatment of bacterial vaginosis in pregnant women. I have avoided the 
use of single 2-g dose of metronidazole, believing it to be less effective than alternatives. I 
will reconsider this practice given the favorable comparisons presented here. 
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